GeneDx Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for GeneDx Holdings Corp. (WGS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-52.29-175.77-548.98-245.39-241.34
Depreciation & Amortization21.9527.1359.3116.218.73
Deferred Income Tax-0.34-0.93-49.120.000.00
Stock Based Compensation9.14-0.3341.98219.42120.23
Change in Working Capital-24.75-38.2433.888.0813.85
Change in Accounts Receivable-5.4210.265.535.54-10.61
Change in Inventory-2.590.982.35-10.62-8.98
Change in Accounts Payable-20.46-46.9534.4625.9214.81
Change in Other Working Capital4.24-2.532.74-11.4419.19
Other Operating Activities4.24-8.272.74-194.422.40
Net Cash from Operating Activities-28.50-180.15-319.16-190.43-93.13
Investing Activities
Capital Expenditures-5.49-5.25-14.32-9.40-24.09
Acquisitions0.00-12.14-127.000.000.00
Purchases of Investments-66.30-29.910.000.000.00
Sales/Maturities of Investments41.66-0.46-7.17-11.39-7.88
Net Cash from Investing Activities-30.13-43.73-141.33-20.79-31.97
Financing Activities
Debt Repayment-3.23-5.60-3.29-13.470.00
Common Stock Issued46.50143.29197.66351.270.00
Other Financing Activities0.890.00197.66155.930.00
Net Cash from Financing Activities44.16186.24197.32493.73129.06
Summary
Net Change in Cash-14.47-37.64-263.17282.513.95
Cash at Beginning of Period100.67138.30401.47118.960.00
Cash at End of Period86.20100.67138.30401.470.00
Free Cash Flow-33.99-185.40-333.48-199.83-117.22
Supplemental Disclosures
Interest Paid6.683.041.932.751.75
Income Taxes Paid1.171.471.240.350.00